DAWNZERA Trademark

Serial Number: 98913107 • Registration: 8235634

DAWNZERA is a trademark filed by Ionis Pharmaceuticals, Inc. on December 19, 2024. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Ionis Pharmaceuticals, Inc. (12 trademarks)

2855 Gazelle Court
Carlsbad, CA 92010

Entity Type: 03

Legal Representation

Attorney of Record

Brian Focarino

367 trademarks filed View all →

Correspondence Address

Brian Focarino Cooley LLP

1299 Pennsylvania Avenue, NW, Suite 700

IP Docketing Department

Washington, DC 20004-2400

United States

Trademark Details

Filing Date

December 19, 2024

Registration Date

April 28, 2026

First Use Anywhere

August 28, 2025

First Use in Commerce

August 28, 2025

Published for Opposition

May 27, 2025

Goods & Services

Medical services; medical information services; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; medical consulting services in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune lymphoproliferative, and rare diseases and disorders, and collecting data and information on autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders